Zdrowie i gospodarka · 28/01/1994

Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products for Over-the-Counter Human Use; Amendment to the Monograph

The Food and Drug Administration (FDA) has issued a final rule amending the monograph for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include 0.6 percent micronized selenium sulfide for dandruff control.